Physician profile
Brian E Barden
NPI 1679557078
$1,060.32
in general payments reported to CMS, 2019-2025
12 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $434 · 2021: $117 · 2022: $106 · 2023: $68.79 · 2024: $39.75 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $234 · Education: $68.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $233.54 |
| Education | $68.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $387.33 | 2020 | |
| Smith+Nephew, INC. | $130.75 | 2019-2021 | |
| Phathom Pharmaceuticals, INC. | $125.00 | 2025 | Voquezna |
| Conmed Corporation | $82.50 | 2022 | |
| Ethicon US, LLC | $71.85 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Davol INC. | $53.00 | 2021-2022 | |
| Kerecis Limited | $50.50 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Aroa Biosurgery Incorporated | $39.75 | 2024 | |
| Polymedics Innovations INC. | $18.29 | 2023 | |
| Acera Surgical, INC. | $17.62 | 2019 | |
| Organogenesis INC. | $15.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Barden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.